Table 1 General characteristics of the patients, operational information, postoperative pathology, and survival-complication results
From: A new technique for closure of pericardial defects: pericardial rug weave
Case | Age | Sex | Side | Tumor size (cm) | Year of Surgery | Operation | Local invasion | Diagnosis | Technic | Stage | Defect Size (cm2) | Complication | Length of Stay |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 66 | Male | Left | 7 | 2018 | IP | Parietal Pericardium | SCC | Rug Weave | T4N1M0 | 32,73 | BPF | 14 |
2 | 65 | Male | Left | 6 | 2022 | Complement Ip + 6-7-8. Ribs Resection | Parietal Pericardium, Ribs | LCLC | Rug Weave | T3N0M0 | 23,81 | None | 7 |
3 | 59 | Male | Right | 6.7 | 2022 | IP + Atrium Resection | Atrium | SCC | Rug Weave | T4N1M0 | 23,04 | Atrial Fibrillation | 13 |
4 | 63 | Male | Left | 5.1 | 2022 | IP | Parietal Pericardium | SCC | Rug Weave | T3N1M0 | 28,36 | None | 6 |
5 | 64 | Male | Left | 5 | 2022 | IP | Parietal Pericardium | SCC | Rug Weave | T4N1M0 | 17,31 | None | 8 |
6 | 61 | Female | Left | 7.2 | 2022 | Neoadjuvant chemotherapy + IP | Parietal Pericardium | SCC | Rug Weave | T4N2M0 | 19,98 | None | 7 |
7 | 75 | Male | Left | 4.7 | 2021 | IP | Parietal Pericardium | SCC | Rug Weave | T3N0M0 | 27,99 | None | 7 |
8 | 63 | Male | Left | 3.8 | 2021 | IP | Parietal Pericardium | SCC | Rug Weave | T3N1M0 | 22,79 | None | 7 |
9 | 63 | Male | Left | 4.2 | 2022 | Neoadjuvant chemotherapy + IP | Parietal Pericardium | SCC | Rug Weave | T3N1M0 | 27,52 | Pneumonia + PTE | 15 |
10 | 72 | Male | Left | 5.3 | 2019 | IP | Parietal Pericardium | SCC | Rug Weave | T3N1M0 | 19,03 | Atrial Fibrillation | 7 |
11 | 56 | Male | Left | 8 | 2021 | IP | Parietal Pericardium | SCLC + LCLC | Rug Weave | T4N0M0 | 24,41 | Atrial Fibrillation | 7 |
12 | 50 | Male | Right | 3 | 2019 | IP | Parietal Pericardium | SCC | Rug Weave | T3N2M0 | 20,57 | None | 6 |
13 | 47 | Male | Left | 7 | 2018 | IP | Parietal Pericardium | SCC | Mesh | T4N2M0 | 27,09 | None | 14 |
14 | 53 | Male | Right | 4 | 2012 | IP | Parietal Pericardium | SCC | Mesh | T4N2M0 | - | None | 9 |
15 | 51 | Male | Right | 20 | 2012 | Neoadjuvant chemotherapy + IP | Parietal Pericardium | LCLC | Mesh | T4N0M0 | - | None | 8 |
16 | 68 | Male | Right | 12 | 2011 | IP + Atrium Resection | Atrium | SCC | Mesh | T4N0M0 | - | Atrial Fibrillation | 6 |
17 | 54 | Male | Right | 4 | 2011 | Neoadjuvant chemotherapy + IP | Parietal Pericardium | SCC | Mesh | T3N1M0 | - | BPF + Pneumonia | 8 |
18 | 77 | Male | Left | 4.2 | 2011 | IP | Parietal Pericardium | SCC | Mesh | T4N2M0 | - | Atrial Fibrillation + BPF + Pneumonia | 21 |
19 | 58 | Male | Left | 10 | 2011 | IP + Atrium Resection | Atrium | SCC | Mesh | T4N1M0 | - | None | 17 |
20 | 58 | Male | Left | 5 | 2011 | IP | Parietal Pericardium | SCC | Mesh | T3N2M0 | - | None | 9 |
21 | 45 | Male | Left | 6 | 2010 | IP | Parietal Pericardium | SCC | Mesh | T3N1M0 | - | None | 6 |
22 | 63 | Male | Left | 6 | 2010 | IP | Parietal Pericardium | SCC | Mesh | T3N1M0 | - | None | 11 |
23 | 48 | Male | Right | 3 | 2010 | IP | Parietal Pericardium | SCC | Mesh | T3N1M0 | - | Atrial Fibrillation | 8 |